Stacey E. P. Joosten

IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis

Rasmus Siersbæk, Valentina Scabia, Sankari Nagarajan et al. · Cancer Cell · 2020 · 258 citations · Full text

Medicine, Cancer Biology, Oncology +14

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

Dario Zimmerli, Chiara Svetlana Brambillasca, Francien Talens et al. · Nature Communications · 2022 · 137 citations · Full text

Medicine, Immunology, Oncology +17

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

Tesa Severson, Yongsoo Kim, Stacey E. P. Joosten et al. · Nature Communications · 2018 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +17

The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers

Irida Kastrati, Stacey E. P. Joosten, Svetlana E. Semina et al. · Molecular Cancer Research · 2020 · 62 citations · Full text

Medicine, Cancer Biology, Oncology +17

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets

Sasagu Kurozumi, Mansour Alsaleem, Cíntia J. Monteiro et al. · Breast Cancer Research · 2020 · 51 citations · Full text

Medicine, Bioinformatics, Oncology +13